Abstract
Although the strategic group and resource based perspectives are frequently presented as mutually exclusive, we argue otherwise. The resource based view informs strategic group analysis through a firm's product or service portfolio by offering a richer perspective on strategy and an additional lens for competitive group interpretation. Products act as the locus and bedrock for corporate decisions and form the backbone upon which market strategies are constructed. A "corporate genome" analogy is presented to illustrate how this process occurs within the U.K. pharmaceutical industry. © 2005 Elsevier Ltd. All rights reserved.
| Original language | English |
|---|---|
| Pages (from-to) | 458-470 |
| Number of pages | 13 |
| Journal | European Management Journal |
| Volume | 23 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - Aug 2005 |
Keywords
- corporate genomes
- pharmaceuticals
- resource-based view
- strategic groups